COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Press Release Publication Half-Year Financial Report 2025
Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases -
-
-
COMMUNIQUÉ DE PRESSE
Cherry SE publishes preliminary results for the third quarter of 2025 – Focus remains on cost reduction and liquidity management
Cherry SE releases preliminary financial results for Q3 2025, showcasing revenue growth and improved EBITDA margin through cost reduction and liquidity management -
COMMUNIQUÉ DE PRESSE
Quadient Takes No. 1 Position in Global Customer Communications Management Software Market Share
Quadient ranked No. 1 in global Customer Communications Management Software Market Share for 2024 by leveraging AI and automation to drive innovation in customer communication strategies -
-
COMMUNIQUÉ DE PRESSE
BioNxt Reports "Readiness to Grant" Patent Notification from the Eurasian Patent Organization
BioNxt Solutions Inc. receives "Readiness to Grant" notification from EAPO for comprehensive patent application on sublingual delivery of anticancer drugs for autoimmune neurodegenerative diseases, including lead product BNT23001 for MS treatment. Patent protection strengthens commercialization strategy -
-
